Greg May Email & Phone Number

Buffalo, New York, United States

Accountable for the sales of oral Tyrosine Kinase Inhibitor (Fotivda) to Academic Cancer Centers and Community Cancer Centers in assigned territory covering Western, Central and Eastern New York State. • 2023 winner of President’s Club finishing with #1 rank in nation (1/44) of all OAM’s, consistent #1 rank for every week and every quarter of 2023.• 120% of 2023 year end goal attainment.• 200% annual volume growth over 2022, including 120 total volume unit growth.• 209% of goal in Q1, 2023, exceeded goal in 3 quarters.• Appointed to the VA field and Sales Ops/Veeva CRM field advisory committees.• New account contest winner for Q3 and Q4, 2021.• Consistently in top 5 of clinical knowledge contests.

Accountable for the sales of Lung Franchise products (Tafinlar/Mekinist and Tabrecta) and Afinitor to Academic Cancer Centers, Hospitals and Community Cancer Centers in assigned territory covering Western New York State.• Tafinlar/Mekinist incentive compensation rank - 14 of 75; Afinitor rank - 7 of 75; Tabrecta is a national goal.• June Pioneer award for going “Above and Beyond” with Tabrecta launch, activity and leadership.• July Pioneer award for best practice sharing with NY Area and Nation, and cross collaboration with Buffalo team and MSL.• Appointed Afinitor Field Based Sales Trainer in July, 2020.• Winner of Tabrecta and Afinitor Boot Camp contests.• Call activity, virtual and live customer engagements and representative triggered e mails at highest level in nation.• Spark awards for collaboration on virtual sales platform, best practice sharing and creation and implementation of Afinitor representative triggered e mails.

Account management and sales of Oncology products to large Academic Cancer Centers and Community Cancer Centers within Western and Central New York State and portions of Northern Pennsylvania. • 2019 Nexavar territory threshold/goal attainment - 112%; 2019 Stivarga territory threshold/goal attainment - 132%.• 2018 year end Nexavar territory threshold/goal attainment - 103%, nation - 93%.• Appointed to Oncology Field Advisory Board in 2018 and 2019.• Appointed to Oncology Incentive Compensation Board and HCC Project Team in 2018.• 2017 year end Stivarga territory threshold attainment - 113%, nation - 92%. • Top (5) accounts total Stivarga change +54. • Top (5) accounts total Nexavar change +8.3.• HCP call plan attainment 66%, Northeast - 62%, Nation - 64%; HCP target frequency - 5.8, Northeast - 4.4, Nation - 4.5.

Accountable for the sales of Hematology Oncology products to Academic Cancer Centers, Hospitals and Community Cancer Centers in assigned territory covering Western and Central New York State and portions of Northern Pennsylvania. • 2016 national rank - 2 of 90 in securing new Granix accounts with a total of 12.• 2016 Treanda to Bendeka conversion rate - 85%, national company goal - 70%.• Ahead of 2016 SBO national detail goals, Bendeka detail attainment - 146%, nation - 138%, Granix - 243%, nation - 206%. • 2015 member and contributor to company region of the year for Northeast Region, rank 1 of 11.

Account management and sales of Oncology products to large Academic Cancer Centers and Community Cancer Centers within Western and Central New York State along with high achievement in scientific knowledge, customer engagement and business acumen knowledge.• 2014 200% of target achievement for Sales Competencies, and Exceptional Integrated Rating as Hematology/Oncology Account Specialist, Achievement Level - 1 of 10. • National Hematology brand point person, and regional product point person for Promacta in 2014, facilitating national and regional product training. • 2013 National Team Champions Award for Western NY Region within Oncology Division, for high ranking in target achievement. • Regional product point person for Arzerra in Western NY Region in 2013, facilitating product training and attending national conventions. • 2013 100% of target achievement for Sales Competencies and Business Unit Measures, as Hematology/Oncology Account Specialist, Achievement Level - 5 of 10. • 2012 Distinguished Integrated Rating as Full Line Oncology Account Specialist, 100% target BU measures, Achievement Level - 3 of 10.

Sales of Medical Center Respiratory and Critical Care products to Hospitals in the Western New York territory, emphasis on strategic account planning, and sales competency.• 2011 Sales Competencies Rating Top 30% of nation as Medical Center Account Manager, 100% target BU measures.• Regional Trainer for Medical Center region in 2011, creating and leading all product and sales training for the region.• 2010 Diamond Winner’s Circle achievement, Medical Center division national rank 7 of 175.• Entereg point person for Medical Center Sales Northern NY Region in 2010, lead on all product training for the region.

Accountable for the sales of CNS/NeuroHealth products to Neurology and Psychiatry Specialties within Western NY territory.• 2010 Completed Regional project – Spring Sprint Teleconference Series, point on planning, implementing and tracking results for Liberty and New England Regions. (1051) total participants for the (12) teleconferences, resulting in over 110% product growth in both regions. • Recipient of GSK 3Vs Award (driving volume by delivering customer value in a values-based way) for Spring Sprint Teleconference Series in 2010.• 2009 Diamond Winner’s Circle achievement, NeuroHealth division national rank 1 of 181.• 2008 NeuroHealth division national rank 69 of 231.• 2007 Diamond Winner’s Circle achievement, NeuroHealth division national rank 20 of 493.• 2006 NeuroHealth division national rank 46 of 260. • Achieved Emerald level status, 100% club, and received passion award in NeuroHealth sales training, for product knowledge, and selling skills scores.

Sales of Burroughs Welcome products to Cardiology, OBGYN, Dermatology, Gastroenterology, Rheumatology and Primary Care within Western New York territory. • 2005 regional rank 3 of 24 as a Burroughs Welcome Representative. • Winner of 2004 Stretch for the goal contest for Wellbutrin XL, regional rank 1 of 24.• 2003 national ranking top 20%.• 2002 Ruby Winner's circle achievement, Burroughs Welcome division, year end regional rank 6 of 36, final national rank 24 of 500.• 2002 MVT (Most Valuable Team) winner for Valtrex, Imitrex, and Wellbutrin SR combined market share growth.• 2001 Valtrex power rating of 111%, rank 3 of 24 representatives in the region, overall power rating of 107%, rank 4 of 24 representatives.• Appointed Orchard Park District Trainer and Valtrex Product Champion, trained new representatives and facilitated company training initiatives.• Facilitated Cross Divisional Meetings for Buffalo, NY area CNS, Respiratory, and HIV divisions, resulting in shared collaboration and achievement of company directives.• Associate Trainer for new sales representatives, helped to train new Burroughs Welcome Representatives on product knowledge and selling skills.